{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:29:04Z","timestamp":1789680544053,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":5715,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1093\/annonc\/mdh183","type":"journal-article","created":{"date-parts":[[2004,4,26]],"date-time":"2004-04-26T14:53:19Z","timestamp":1082991199000},"page":"726-732","source":"Crossref","is-referenced-by-count":28,"title":["An oncologist-based model of cancer genetic counselling for hereditary breast and ovarian cancer"],"prefix":"10.1016","volume":"15","author":[{"given":"A.","family":"Contegiacomo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pensabene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Capuano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Tauchmanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Federico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Turchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Cortesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Ricevuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Cianci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Venuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Silingardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdh183_bb0010","first-page":"49","article-title":"Update on breast cancer susceptibility genes. Recent Results","volume":"152","author":"Weber","year":"1998","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdh183_bb0015","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s004320000140","article-title":"BRCA1 and BRCA2-breast cancer susceptibility genes","volume":"126","author":"Hofmann","year":"2000","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1093\/annonc\/mdh183_bb0020","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1200\/JCO.1994.12.8.1724","article-title":"Quantitating familial cancer risk: a resource for clinical oncologists","volume":"12","author":"Offit","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh183_bb0025","series-title":"Diseases of the Breast","first-page":"1","article-title":"Familial breast cancer: recent advances","author":"Weber","year":"1998"},{"key":"10.1093\/annonc\/mdh183_bb0030","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"key":"10.1093\/annonc\/mdh183_bb0035","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1126\/science.8091231","article-title":"Localization of a breast susceptibility gene BRCA2 to chromosome 13q1213","volume":"265","author":"Wooster","year":"1994","journal-title":"Science"},{"key":"10.1093\/annonc\/mdh183_bb0040","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/(SICI)1097-0142(19991015)86:8+<1705::AID-CNCR9>3.0.CO;2-K","article-title":"Integration of family history and medical management of patients with hereditary cancers","volume":"86","author":"Lynch","year":"1999","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdh183_bb0045","first-page":"889","article-title":"Risk of breast and ovarian cancer in women with strong family histories","volume":"15","author":"Srivastava","year":"2001","journal-title":"Oncology"},{"key":"10.1093\/annonc\/mdh183_bb0050","first-page":"159","article-title":"Role of the genetic counselor in familial cancer","volume":"10","author":"Peters","year":"1996","journal-title":"Oncology"},{"key":"10.1093\/annonc\/mdh183_bb0055","article-title":"American College of Medical Genetics. Genetic Susceptibility to Breast and Ovarian Cancer: Assessment, Counseling and Testing Guidelines","year":"1999","journal-title":"New York State Department of Health"},{"key":"10.1093\/annonc\/mdh183_bb0060","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/jama.1995.03520310075033","article-title":"Assessment and counseling for women with a family history of breast cancer. A guide for clinicians","volume":"273","author":"Hoskins","year":"1995","journal-title":"J Am Med Assoc"},{"key":"10.1093\/annonc\/mdh183_bb0065","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1200\/JCO.2003.03.189","article-title":"American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer Susceptibility","volume":"21","author":"Clin Oncol","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh183_bb0070","first-page":"1477","article-title":"Genetic risk counseling for breast cancer families","volume":"34","author":"Hopwood","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdh183_bb0075","first-page":"747","article-title":"Familial breast and ovarian cancer: genetic counseling and clinical management in Italy","volume":"10","author":"Pasini","year":"1999","journal-title":"Epidemiology"},{"key":"10.1093\/annonc\/mdh183_bb0085","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1023\/A:1011176107455","article-title":"Cancer genetics in oncology practice","volume":"12","author":"Olopade","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdh183_bb0090","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1023\/A:1006192230332","article-title":"Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: the Modena Study Group proposal","volume":"55","author":"Federico","year":"1997","journal-title":"Breast Cancer Res Treat"},{"key":"10.1093\/annonc\/mdh183_bb0095","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1200\/JCO.1998.16.7.2417","article-title":"Sequence analysis of BRCA1 and BRCA2: correlation of mutation with family history and ovarian cancer risk","volume":"16","author":"Frank","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh183_bb0100","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5","article-title":"Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction","volume":"73","author":"Claus","year":"1994","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdh183_bb0105","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM200002243420807","article-title":"Primary care assessing the risk of breast cancer","volume":"342","author":"Armstrong","year":"2000","journal-title":"New Engl J Med"},{"key":"10.1093\/annonc\/mdh183_bb0110","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/jnci\/90.23.1824","article-title":"Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history","volume":"90","author":"Claus","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdh183_bb0115","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1016\/S0959-8049(98)00288-3","article-title":"Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family breast clinics","volume":"34","author":"Vasen","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdh183_bb0120","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1023\/A:1008389021382","article-title":"Recommendation for medical management of hereditary breast and ovarian cancer. The French National Ad Hoc Committee","volume":"9","author":"Eisenger","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdh183_bb0125","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/jama.1997.03540360065034","article-title":"Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2 Cancer Genetics Studies Consortium","volume":"277","author":"Burke","year":"1997","journal-title":"J Am Med Assoc"},{"key":"10.1093\/annonc\/mdh183_bb0130","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.286.18.2251","article-title":"National Surgical Adjuvant Breast and Bowel Project: Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial","volume":"286","author":"King","year":"2001","journal-title":"J Am Med Assoc"},{"key":"10.1093\/annonc\/mdh183_bb0135","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(00)03258-X","article-title":"Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case\u2013control study. Hereditary Breast Cancer Clinical Group","volume":"356","author":"Narod","year":"2000","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdh183_bb0140","first-page":"222","article-title":"Bilateral prophylactic mastectomy (PM) in BRCA1\/2 mutation carriers","volume":"41","author":"Hartmann","year":"2000","journal-title":"Proc Am Assoc Cancer Res"},{"key":"10.1093\/annonc\/mdh183_bb0145","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jama.1995.03520300065039","article-title":"Ovarian Cancer. Screening, treatment and follow-up. NIH Consensus Development Panel on Ovarian Cancer","volume":"273","author":"NIH Consensus Conference","year":"1995","journal-title":"J Am Med Assoc"},{"key":"10.1093\/annonc\/mdh183_bb0150","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations","volume":"23","author":"Rebbeck","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdh183_bb0155","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1001\/jama.1996.03530480027036","article-title":"BRCA1 testing in families with hereditary breast\u2013ovarian cancer. A prospective study of patient decision-making and outcomes","volume":"275","author":"Lerman","year":"1996","journal-title":"J Am Med Assoc"},{"key":"10.1093\/annonc\/mdh183_bb0160","first-page":"745","article-title":"Recommendations for standardized human pedigree nomenclature","volume":"56","author":"Bennett","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1093\/annonc\/mdh183_bb0165","unstructured":"Comitato nazionale per la biosicurezza e le biotecnologie. Istituto Superiore di Sanit\u00e0 (ISS). Linee guida per test genetici. http:\/\/www.iss.it\/scientifica\/pubblica\/lineguida\/genetici.htm"},{"key":"10.1093\/annonc\/mdh183_bb0170","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/sj.onc.1200881","article-title":"Strong indication for breast cancer susceptibility gene on chromosome 8p12-p22: linkage analysis in German breast cancer families","volume":"14","author":"Seitz","year":"1997","journal-title":"Oncogene"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419557829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419557829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/15\/5\/726\/463985\/mdh183.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T17:54:35Z","timestamp":1582221275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419557829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0923753419557829"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdh183","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}